Analysts Have Conflicting Sentiments on These Healthcare Companies: Ocular Therapeutix (OCUL) and ModivCare (MODV)
ModivCare Analyst Ratings
Lake Street Reaffirms Their Hold Rating on ModivCare (MODV)
Deutsche Bank Adjusts ModivCare Price Target to $26 From $60, Maintains Hold Rating
ModivCare Analyst Ratings
Lake Street Downgrades ModivCare to Hold From Buy, Cuts Price Target to $50 From $100
ModivCare Analyst Ratings
ModivCare's Challenging Outlook: Operational Headwinds Prompt Hold Rating
ModivCare: Hold Rating Justified by Mixed Performance and Cautious FY24 Outlook Amid Contract Challenges
ModivCare Analyst Ratings
Barrington Raises Price Target on ModivCare to $68 From $58, Maintains Outperform Rating
Analysts' Top Healthcare Picks: ModivCare (MODV), Clearside Biomedical (CLSD)
ModivCare Earns Buy Rating From Analyst Michael Petusky Amidst Q3 Profitability and Bright Future Prospects
Analysts Offer Insights on Healthcare Companies: ModivCare (MODV), Alcon (ALC) and Humana (HUM)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), ModivCare (MODV) and Staar Surgical (STAA)
ModivCare's Stock: A Buy Rating Based on Revenue Growth, Cash Flow Improvement, and Management's Forecasting Proficiency
Barrington Sticks to Their Buy Rating for ModivCare (MODV)
Lake Street Adjusts ModivCare Price Target to $100 From $135, Maintains Buy Rating
Deutsche Bank Maintains Buy on ModivCare, Lowers Price Target to $50
ModivCare Analyst Ratings
No Data